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SUMMARY 
 
An adult female Elephant Trunk Snake (Acrochordus javanicus) was reported to have been weak and inappetent for five 
days. The following morning the snake found dead, while in the process of shedding its skin. On post mortem examination, there 
were multiple circumscribed caseous nodules of various sizes distributed all over the liver, along the respiratory tract and on the 
lungs. Bacteriological analysis of the lungs and liver swab samples yielded Burkholderia pseudomallei, which was confirmed by 
PCR amplification of specific 16S rRNA. The condition was diagnosed as melioidosis and the organism was genotypically 
characterized as sequence type 51, a genotype that has been previously characterized in humans in Malaysia. Antibiotic 
susceptibility by both Disc diffusion or Kirby Bauer and E-test minimum inhibitory concentration (MIC) showed that the organism 
exhibited susceptibility to meropenem, imipenem, ceftazidime, cotrimoxazole and co-amoxyclav; the antibiotics recommended in 
the treatment of melioidosis. 
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INTRODUCTION 
 
Melioidosis, a likely fatal infectious disease of both 
humans and animals is caused by an environmental (soil 
and water) dwelling saprophytic bacterium; Burkholderia 
pseudomallei (Inglis and Sousa, 2009; Currie et al., 2010). 
The disease was now known to be hyperendemic in some 
parts of Southeast Asia and northern Australia (Currie et 
al., 2008). It is believed that the disease is now expanding 
beyond its traditionally known endemic region to other 
tropical regions of the world, including the Indian 
subcontinent, southern China, Hong Kong, Taiwan, Brazil 
and Malawi (Currie et al., 2008; Katangwe et al., 2013). 
However it is still unclear whether the infection has been 
there but hitherto undetected (Dance, 2000). There are 
unconfirmed reports of new cases in South Africa and the 
Middle East, while some imported cases are described in 
several temperate countries (Dance, 2000). Transmission 
of the disease, in both humans and animals, are believed 
to occur most often via traumatic skin inoculation and 
through ingestion or inhalation of contaminated soil and 
water (White, 2003). There are evidences of infections 
acquired following near drowning events and rarely from 
sexual transmission (McCormick et al., 1975; 
Pruekprasert and Jitsurong, 1991; Cheng and Currie, 
2005; Mukhopadhyay et al., 2009). Emergences of 
melioidosis related to travelling and importation of cases 
have been observed in developed countries of the world 
(Currie et al., 2008). Virtually all organs of the body in 
both humans and animals can be infected by the disease 
(Puthucheary and Vadivelu, 2002; Sprague and Neubauer, 
2004). The clinical spectrum of melioidosis may range 
from indolent localised infection to fulminating 
septicaemia (Currie et al., 2000). Treatment of melioidosis 
can be done usually by antibiotic chemotherapy to 
improve patients’ condition and disease control (Cheng 
and Currie, 2005). There are two distinct phases of  
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antibiotic treatments used to treat melioidosis: (a) the 
acute septicaemic phase of the disease or intensive phase, 
using the cephalosporin, ceftazidime and carbapenems, 
meropenem and imipenem and (b) the subsequent 
eradication phase treatment using trimethoprim-
sulfamethoxazole (cotrimoxazole) (Inglis, 2010). Due to 
the organisms’ high level of intrinsic resistance against 
many common clinically available antibiotics, antibiotic 
treatment of this infection is proving difficult (Simpson et 
al., 1999). Melioidosis fatality rate may range from 20 to 
40% even with expeditious diagnosis and prompt and 
vigorous antibiotic treatment (Schweizer, 2012). 
Melioidosis is a disease of public health significance and 
its public health implications have been previously 
reviewed (Inglis and Sousa, 2009). Previously it has been 
shown that importations of animals with melioidosis into 
areas that have been known to be free from the disease 
have resulted in outbreaks and subsequent persistence of 
B. pseudomallei in the contaminated soil (Galimand and 
Dodin, 1982). It has been known that human to 
humantransmission of this disease is rare; anecdotal 
evidences of zoonotic transmission of the organism from 
animal to human do exist. Animals with melioidosis may 
shed the B. pseudomallei via bodily discharges with 
consequent increase in the risk of direct animal to animal, 
or animal to human disease transmission (Idris et al., 
1998; Choy et al., 2000; Currie, 2010). Melioidosis has 
been previously reported in camels (Forbes-Faulkner et 
al., 1992), alpacas (Janmaat et al., 2004), swine 
(Najdenski et al., 2004), captive whales and dolphins 
(Hicks et al., 2000), deer (Srikawkheaw and Lawhavinit, 
2007), feline (O'Brien et al., 2003), canine and wild avian 
(Ouadah et al., 2007) and pet iguana (Iguana iguana) 
(Zehnder et al., 2014). There has been no published report 
of cases of melioidosis in snakes. Therefore this paper 
presents a case of fatal melioidosis in a captive Elephant 
trunk snake (Acrochordus javanicus) in Kuala Lumpur, 
Malaysia and phylogenetic assessment of the aetiological 
agent. 
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CASE REPORT 
 
History 
 
An adult female Elephant Trunk Snake 
(Acrochordus javanicus), 159 cm in length, that has been 
housed in a specially made plastic aquarium in a private 
facility in Kuala Lumpur, Malaysia was reported to have 
been weak and inappetent for about four to five days. In 
the morning, the snake was found dead while in the 
process of shedding its skin. 
 
Post-mortem and Histopathology findings 
 
Post-mortem examination of the carcass was carried 
out, the body condition score of the snake was estimated 
to be 3/5, although the snake has naturally loose skins and 
folds, there was evidence of exoskeletal shedding. 
Necropsy findings showed no pathological lesions along 
the gastrointestinal tract (GIT), however the GIT was 
found to be empty with presence of yellowish mucus. 
There were multiple circumscribed caseous nodules of 
various sizes scattered all over the liver, respiratory tract 
and lungs. These circumscribed protruding caseous 
nodules were particularly more pronounced in the lungs 
and when the surface of the lungs was cut, there was the 
presence of a cheesy exudate and numerous nodular 
structures (Figure 1).  
 
Figure 1: Gross picture of the lung (snake), showing 
(a) numerous circumscribed protruding nodules. The 
cut surface of the lungs showing the presence of cheesy 
exudate and numerous nodular structures (arrows) 
 
Lung biopsy and tissue swabs of both the lungs and 
liver were taken using sterile swab and sent to 
histopathology and bacteriology laboratories respectively. 
The lung biopsy was sent to the histopathology 
laboratory of the Faculty of Veterinary Medicine (FPV, 
UPM) in 10% buffered formalin where it was processed, 
sectioned  and stained with Hematoxylin and Eosin 
(H&E) stain for light microscopic examination of lesions 
at various magnifications (100× and 200×). 
The histopathological lesions observed varied from 
an immature to matured garanuloma formation with a 
centeral area of necrosis containing pus, tissue debris and 
calcium deposits with calcified wall. Leucocytic 
infiltration in the interstitium and connective tissue 
proliferation around the granuloma were also observed. 
Figures 2 to 5 below showed the varying degrees of 
lesions observed in the melioidosis positive elephant 
snake’s lungs. 
 
Bacteriological examination 
 
The swab samples were sent to bacteriology 
laboratory of the Faculty of Veterianary Medicine, 
Universiti Putra Malaysia (UPM). Following primary 
culture and subculture on Blood  and MacConkey agar, 
screening was don based on  Gram staining reaction, 
colony morphology, positive culture on Ashdown’s agar, 
and oxidase and catalase tests. Presumptive identification 
of this organism was based on its appearance as bipolar 
Figure 2: An immature granuloma (G) in the lung of a 
melioidosis positive snake. Note the necrotic center 
(N), surrounded by leucocyte infiltration (LI) in the 
interstitium and partial calcification (C), H&E ×100 
 
 
Figure 3: A mature granuloma in the lung of a 
melioidosis positive snake. Note the necrotic center (N) 
containing debris and calcium deposits (D), 
surrounding leucocyte infiltration (LI) around the 
periphery, a calcified wall (W) and concentric layers of 
fibrous connective tissue (CT), H&E ×200 
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organisms, oxidase positive, catalase negative,Gram 
negative bacilli with characteristic colonies on Ashdown’s 
agar that were purple, flat, dry and wrinkled according to 
(Chantratita et al., 2007).Pure colonies were obtained 
from the subculture and nucleic acid was extracted using 
Qiagen DNeasy (Qiagen, Germany) bacterial DNA 
extraction kit,  used according to manufacturer’s 
instructions. Confirmation of the isolate as B. 
Pseudomalleiwas done by polymerase chain reaction 
(PCR) amplification of 600bp gene fragment using 
B.pseudomallei specific 16S rRNA region primers 
(PPM3- forward primer) 5'-
AATCATTCTGGCTAATACCCG-3' and (PPM4- reverse 
primer) 5’-CGGTTCTCTTTCGAGCTCG-3' obtained 
from a previous study by Brook et al. (1997). 
Figure 4: An immature granuloma (G) in the lung of a 
melioidosis positive snake adjacent to a matured 
granuloma (MG). Note the necrotic center (N), 
surrounded by leucocyte infiltration (LI) in the 
interstitium, partial calcification (C) and connective 
tissue proliferation around the granuloma (CT), H&E 
×100 
 
 
 
Figure 5: An immature granuloma in the lung of a 
melioidosis positive snake, adjacent to a matured 
granuloma (MG). Note the necrotic center (N), 
surrounded by leucocyte infiltration (LI) , partial 
calcification (C), and connective tissue proliferation 
around the granuloma (CT) (C), H&E ×100 
 
 
 
Figure 6: Gel electrophoreses picture of 550bp  B. 
pseudomallie 16S rRNA gene fragment. Positive 
control (+Contrl), Negative control (-Contrl), snake 
lung isolate (1) and snake liver isolate (2) 
 
PCR amplification was confirmed by gel electrophoresis 
using 1.5% agarose gel (Promega, USA) electrophoresis 
in 1X TBE buffer at 90Volts for 1 hour and visualised 
using ethidium bromide staining under UV illumination 
(Figure 6). 
 
Molecular characterisation of the B. pseudomallei isolate 
from the snake 
 
Genetic typing of the isolate was done by multilocus 
sequence typing (MLST) by PCR amplification of the 
seven housekeeping genes according to Godoy et al. 
(2003). PCR products were confirmed by gel 
electrophoresis using 1.5% agarose gel (Promega, USA) 
electrophoresis in 1X TBE buffer at 90Volts for 1hour and 
visualised using ethidium bromide staining under UV 
illumination. The PCR products of each of the seven 
housekeeping genes were purified using MEGAquick-spin 
(iNtRON Biotechnology, Korea) purification kits 
according to manufacturer’s instructions.The purified 
PCR products were sequenced by Sanger sequencing 
method, using the same primers that were used for the 
initial PCR amplification.The sequence for each gene 
fragments were aligned and trimmed to the appropriate 
size for each locus before queried on the MLST database 
to get the allele number. The housekeeping genes and 
their corresponding allele numbers are ace3, gltB1, 
gmhD2, lepA3, lipA1, narK4 and ndh3 these combination 
of alleles were queried in this order on the MLST profile 
query to obtain the B. pseudomallie isolate’s sequence 
type as 51 (ST51). 
 
Antibiotic susceptibility test (AST) 
 
Antibiotic susceptibility by both Disc diffusion or 
Kirby Bauer (12 antibiotics) and E-test minimum 
inhibitory concentration (MIC) (five antibiotics) evaluator 
strip antibiotics methods were conducted. Disc diffusion 
test showed that the isolate was susceptible to 
meropenem, imipenem, ceftazidime, doxycycline, 
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chloramphenicol, ceftriaxone, tetracycline, ciprofloxacin, 
and trimethoprim/sulfamethoxazole (cotrimoxazole) while 
resistant to azteonam, gentamycine and ticarcillin. E-test 
MIC test showed that the isolate from the snake  was 
suceptible to antibiotics tested; meropenem, imipenem, 
ceftazidime, cotrimoxazole and amoxycillin/clavulanic 
acid (co-amoxyclav).  
 
Diagnosis 
 
Based on the gross pathological and histological 
lesions a tentative diagnosis of granulomatous pneumonia 
was made. A definitive diagnosis of melioidosis  was 
made following the isolation, identification and 
characterization of B. pseudomallei ST51. 
 
DISCUSSION 
 
The Elephant Trunk Snake (Acrochordus javanicus), 
a non-venomous aquatic and nocturnal snake, is found in 
Southeast Asia, Papua New Guinea, India and Northern 
Australia and it is most common in Malaysia (Sanders et 
al., 2012). Melioidosis, an infection with B. pseudomallei 
affects a wide range of animal species,horses (Ladds et 
al., 1981), sheep and goats (Fatimah et al., 1984; Barbour 
et al., 1997),monkeys (Dance et al., 1992; Yap et al., 
1995), deer (Babjee and Nor Aidah, 1994; Choy et al., 
2000), cats and dogs (Yap et al., 1995; O'Brien et al., 
2003) and pet iguana (Zehnder et al., 2014). The 
incubation period of this disease in naturally infected 
animal is still not known (Sprague and Neubauer, 2004), 
however, the clinical presentation varies in both humans 
and animals (Puthucheary and Vadivelu, 2002; Sprague 
and Neubauer, 2004). In animals, the signs may range 
from acute fulminant septicaemia, localised infection, 
subacute disease to chronic infection and subclinical 
(inapperant) disease (Sprague and Neubauer, 2004). In 
this case, the time of onset of the disease in the snake was 
not known and vague signs of inappetence and weakness 
were the only signs observed prior to its death. These non-
specific signs are similar to reluctance or refusal to 
perform, lethargy and dullness, dyspnoea and partial to 
complete anorexia as described among marine mammals 
with melioidosis (Kinoshita, 2008). In this case, the 
necropsy findings in the snake showed multiple 
circumscribed protruding purulent nodules all over the 
lungs and the liver. These finding are consistent with 
those described by Omar (1963), who reported that the 
typical gross pathological features of melioidosisis the 
formation of multiple abscesses in most of the organs. 
Such multiple nodules or abcesses, especially in the lungs 
and associated lymph nodes, but also in the liver and the 
spleen were observed to be typical characteristics of 
subacute melioidosis (Sprague and Neubauer, 2004). In 
this case, multiple abscesses of different sizes were found 
on the liver and clustering along the respiratory tract and 
particularly more pronounced in the lungs. This finding 
seem to be in tandem with the observation of Choy et al. 
(2000), that the lungs, spleen, liver and associated lymph 
nodes appear to be the most commonly affected organs. 
Histopathologically, the snake lungs revealed the presence 
of immature to matured garanuloma formation, central 
area of necrosis containing pus, tissue debris and calcium 
deposits around the granuloma wall, with leucocytic 
infiltration in the interstitium. Hicks et al. (2000), has 
decribed the typical histopathological lesions of 
melioidosis regardless of the tissue type as a focal 
necrosis, hemorrhage, fibrin exudation, microabscesses 
with variable accumulation of polymorphonuclear 
neutrophils mainly distributed in the lungs, liver and 
spleen. 
The or definitive diagnosis of meloidosis is isolation 
and identification of the causative agent (Leelarasamee 
and Bovornkitti, 1989; Limmathurotsakul et al., 2010). In 
this case, both the lung and liver swabs yielded an 
organism that was phenotypically, biochemically and 
molecularly identified as B. pseudomallei. Dance et al. 
(1989) and Walsh and Wuthiekanun (1996), have 
described that this organism can simply be identified by 
its colonial morphology on Ashdown’s medium, 
biochemical profile and antibiotic susceptibility patterns. 
Several genetic identification techniques are now 
employed as an alternative or complementary 
identification method to established phenotypic methods. 
In this case, identification of B. pseudomallei targeting the 
16SrRNA gene fragment specific for this organism was 
used. This PCR based test was proven to be a more 
sensitive method than culture and it is a useful 
confirmatory test in determining the identity of isolates 
where conventional biochemical tests gave ambiguous 
results (Brook et al., 1997). 
The environmental saprophyte B. pseudomallei have 
been known to be biogeographically and phylogenetically 
variable. Several previous studies have suggested 
biogeographical clustering of B. pseudomallei strains and 
genotypes (Vesaratchavest et al., 2006; Currie et al., 
2007; Pearson et al., 2009; Dale et al., 2011; McRobb et 
al., 2014). In this case, we characterised the isolate from 
the snake using MLST which showed it to be B. 
pseudomallei ST51. Currently there are 66 ST51 isolates 
on the MLST database, whereby over 88% were reported 
from melioidosis cases in humans (Godoy et al., 2003) 
and from water (McCombie et al., 2006), mainly from 
Thailand, Malaysia, Singapore and Cambodia. The source 
of the infection cannot be ascertained because we could 
not get the clients cooperation to get water sample which 
we thought could be the source of the infection. However 
this type of snakes are naturally aquatic, the disease might 
have been acquired before captivity in its natural 
environment. Being the predominantly found ST in 
Malaysia, eBURST algorithm of B. pseudomallei ST51 
has shown that this ST was resolved into the major 
Malaysian clonal complex 50 (CC50) with ST50 as the 
complex predicted founder. When compared with the 
global deposited B. pseudomallei isolates, B. pseudomallei 
ST51 was found to belong to the major Southeast Asian 
CC48 as double locus variant (DLV) to the CC founder 
ST48.This ST being previously isolated from human cases 
signifies the public health implications of the B. 
pseudomallei isolates with ST51.This can be attributed to 
the fact that animals with melioidosis might be shedding 
the organism via external wound exudates and other 
bodily secretions such as nasal, milk, faeces and urine, 
thereby contaminating the environment and increasing the 
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risk of bacterial transmission to humans and other animals 
(Idris et al., 1998; Choy et al., 2000; Currie, 2010). This 
was evidenced by an outbreak of melioidosis from an 
importation of infected animals with subsequent 
environmental contamination and persistence of infection 
in a zoo in Paris, France (Dodin, 1992; Dodin and 
Galimand, 1986).  
Burkholderia pseudomallei is naturally resistant to a 
variety of antibiotics that include most penicillins, all 
narrow-spectrum cephalosporins, all macrolides, all 
polymyxins, and the aminoglycosides (Livermore, 1987; 
Moore et al., 1999; Sam et al., 2009). This intrinsic ability 
of the organism to resist antimicrobial agents makes the 
treatment of melioidosis difficult. The treatment of 
melioidosis is divided into two phases; the acute or 
intensive and eradication phases (Lipsitz et al., 2012). 
Antibiotic treatment of melioidosis is often prolonged, 
cost intensive and often unsuccessful if not properly 
implemented (Choy et al., 2000). Due to the risks of 
contamination of the environment with body secretions 
and discharges from infected animals, treatment of 
animals with melioidosis is not usually recommended. 
Furthermore, the optimum doses and regimen of 
antibiotics for treatment of melioidosis has not yet been 
ascertained. Infected animals are usually destroyed by 
incineration (FAO, 2004). 
Because of the natural resistance of this bacterium to 
antibiotics, antibiotic susceptibility testing is 
recommended. In this case, antibiotic susceptibility test 
was done using both disc diffusion and E-test MIC 
evaluation tests. The disc diffusion test showed that the B. 
pseudomallei isolate was susceptible to meropenem, 
imipenem, ceftazidime, doxycycline, chloramphenicol, 
ceftriaxone, tetracycline, ciprofloxacin and cotrimoxazole. 
The susceptibility of B. pseudomallei to these antibiotics 
was consistent with several previous works (Jenney et al., 
2001; Ahmad et al., 2013; Bandeira et al., 2013; Khosravi 
et al., 2014). On the other hand, the isolates in this study 
showed resistance to azteonam, gentamycin and 
ticarcillin. In a previous study, Cheng and Currie (2005),  
described that B. Pseudomalleiwas resistant to  first, 
second, and third-generation cephalosporins; penicillins 
and polymyxin B, while natural resistance to 
aminoglycosides was described by Moore et al. (1999). 
The five drugs that are involved in the treatment of 
melioidosi are ceftazidime or carbapenem (either 
meropenem or imipenem), used in the intensive phase 
treatment and cotrimoxazole in the eradication phase 
treatment with co-amoxyclav as its substitute (Lipsitz et 
al., 2012). In this case, the isolate from the elephant trunk 
snake was suceptible to meropenem, imipenem, 
ceftazidime, cotrimoxazole and co-amoxyclav by E-test 
MIC method. This outcome further upholds the current 
recommendation of the workshop on antibiotic treatment 
and post-exposure prophylaxis of B. pseudomallei and B. 
mallei in 2010 (Lipsitz et al., 2012). 
Having diagnosed the condition, the client’s 
attention was drawn on the potential risk of this disease to 
public health and the need to take personal protective 
measures. Immediate disinfection of the premises of the 
snake with 10% solution of sodium hydroxide (NaOH) or 
5% formaldehyde was recommended, while the snake 
carcass was incinerated. It can be concluded that B. 
pseudomallei can cause a fatal melioidosis in elephant 
trunk snakes. The gross and histopathological lesions 
showed a circumscribed pus containing granuloma. 
Bacterial isolation and characterisation identified an 
organism with an ST51 similar to what was previously 
reported in human cases of melioidosis. The organism was 
susceptible to antibiotics recommended for treatment of 
melioidosis. Personal protective measures and disinfection 
of the premises have been recommended. 
 
CONFLICT OF INTEREST 
 
We declare that we have no conflict of interest. 
 
ACKNOWLEDGEMENTS 
 
The authors wish to offer their gratitude to the staff 
of Bacteriology Laboratory and Histopathology 
Laboratory, Department of Veterinary Pathology and 
Microbiology Faculty of Veterinary Medicine Universiti 
PutraMalaysia for their technical assistance.This case 
study was supported by Universiti Putra Malaysia 
Research Grant GP-T/2013/9419100. 
 
REFERANCES 
 
Ahmad N., Hashim R., Mohd Noor A. (2013). The In Vitro 
Antibiotic Susceptibility of Malaysian Isolates of Burkholderia 
pseudomallei. International Journal of Microbiology. 2013. 
Babjee M.A., Nor Aidah A.R. (1994). Melioidosis in animals, in: 
S. D. Puthucheary and Y. A. Malik (Eds.), Melioidosis: Prevailing 
Problems and Future Directions, SP-Muda Printing, Kuala Lumpur, 
Malaysia. pp. 112–122. 
Bandeira T.J., Brilhante R., Rocha M., Moreira C.A., Cordeiro 
R.A., Ribeiro J.F., Castelo-Branco D.S., Sidrim J. (2013). In vitro 
antimicrobial susceptibility of clinical and environmental strains of 
Burkholderia pseudomallei from Brazil. International Journal of 
Antimicrobial Agents. 42:375. 
Barbour E., Nabbut N., Hamadeh S., Al-Nakhli H. (1997). 
Bacterial identity and characteristics in healthy and unhealthy respiratory 
tracts of sheep and calves. Veterinary Research Communications. 
21:421-430. 
Brook M., Currie B., Desmarchelier P. (1997). Isolation and 
identification of Burkholderia pseudomallei from soil using selective 
culture techniques and the polymerase chain reaction. Journal of Applied 
Microbiology. 82:589-596. 
Chantratita N., Wuthiekanun V., Boonbumrung K., Tiyawisutsri 
R., Vesaratchavest M., Limmathurotsakul D., Chierakul W., 
Wongratanacheewin S., Pukritiyakamee S., White N.J. (2007). 
Biological relevance of colony morphology and phenotypic switching by 
Burkholderia pseudomallei. Journal of Bacteriology. 189:807-817. 
Cheng A.C., Currie B.J. (2005) Melioidosis: epidemiology, 
pathophysiology, and management. Clinical microbiology Reviews 
18:383-416. 
Choy J.L., Mayo M., Janmaat A., Currie B.J. (2000). Animal 
melioidosis in Australia. Acta Tropica. 74:153-158. 
Currie B.J. (2010). Burkholderia pseudomallei and Burkholderia 
mallei: Melioidosis and Glanders, in: G. L. Mandell, Bennett, J. E. and 
Dolin, R. (Ed.), Mandell, Douglas, and Bennett's principles and practice 
of infectious diseases, Elsevier, 1600 John F. Kennedy Blvd. Suite 1800 
Philadelphia, PA 19103. pp. 2869-2879. 
Currie B.J., Dance D.A., Cheng A.C. (2008). The global 
distribution of Burkholderia pseudomallei and melioidosis: an update. 
Transactions of the Royal Society of Tropical Medicine and Hygiene. 
102:S1-S4. 
Currie B.J., Fisher D.A., Anstey N.M., Jacups S.P. (2000). 
Melioidosis: acute and chronic disease, relapse and re-activation. 
Transactions of the Royal Society of Tropical Medicine and Hygiene 
94:301-304. 
J. Vet. Malaysia (2016) 28 (1):20-26 
25 
 
Currie B.J., Thomas A.D., Godoy D., Dance D.A., Cheng A.C., 
Ward L., Mayo M., Pitt T.L., Spratt B.G. (2007). Australian and Thai 
isolates of Burkholderia pseudomallei are distinct by multilocus 
sequence typing: revision of a case of mistaken identity. Journal of 
Clinical Microbiology. 45:3828-3829. 
Currie B.J., Ward L., Cheng A.C. (2010). The epidemiology and 
clinical spectrum of melioidosis: 540 cases from the 20 year Darwin 
prospective study. PLoS Neglected Tropical Diseases 4:e900. 
Dale J., Price E.P., Hornstra H., Busch J.D., Mayo M., Godoy D., 
Wuthiekanun V., Baker A., Foster J.T., Wagner D.M. (2011). 
Epidemiological tracking and population assignment of the non-clonal 
bacterium, Burkholderia pseudomallei. PLoS Neglected Tropical 
Diseases. 5:e1381. 
Dance D., King C., Aucken H., Knott C., West P., Pitt T. (1992). 
An outbreak of melioidosis in imported primates in Britain. The 
Veterinary Record. 130:525-529. 
Dance D., Wuthiekanun V., Naigowit P., White N. (1989). 
Identification of Pseudomonas pseudomallei in clinical practice: use of 
simple screening tests and API 20NE. Journal of Clinical Pathology. 
42:645-648. 
Dance D.A.B. (2000) Melioidosis as an emerging global problem. 
Acta Tropica 74:119. 
Dodin A. (1992) Naissance, vie... et assoupissement d'une 
maladie infectieuse: la melioidose. Annales de l'Institut Pasteur. 3:267-
270. 
Dodin A., Galimand M. (1986). Origin, course and recession of 
an infectious disease, melioidosis, in temperate countries. Archives de 
l'Institut Pasteur de Tunis 63:69. 
FAO. (2004). Good Practices for the Meat Industry, Animal 
Production and Health manual 2, Food and Agriculture Organization 
(FAO) of the United Nations Rome, Italy. pp. 15-54. 
Fatimah I., Ikede B., Mutalib R. (1984). Granulomatous orchitis 
and periorchitis caused by Pseudomonas pseudomallei in a goat. 
Veterinary Record 114:67-68. 
Forbes-Faulkner J., Townsend W., Thomas A. (1992). 
Pseudomonas pseudomallei infection in camels. Australian Veterinary 
Journal. 69:148-148. 
Galimand M., Dodin A. (1982) Repartition de Pseudomonas 
pseudomallei en france et dans le monde la melioidose. Bulletin de la 
Societé Vétérinaire Pratique de France. 66:651-657. 
Godoy D., Randle G., Simpson A.J., Aanensen D.M., Pitt T.L., 
Kinoshita R., Spratt B.G. (2003). Multilocus sequence typing and 
evolutionary relationships among the causative agents of melioidosis and 
glanders, Burkholderia pseudomallei and Burkholderia mallei. Journal of 
Clinical Microbiology. 41:2068-2079. 
Hicks C., Kinoshita R., Ladds P. (2000). Pathology of melioidosis 
in captive marine mammals. Australian Veterinary Journal. 78:193-195. 
Idris A., Rachmat R., Ali S.M. (1998). Melioidosis: a case of 
sheep to human transmission. Jurnal Veterinar. Malaysia. 10:77-79. 
Inglis T.J. (2010) The treatment of melioidosis. Pharmaceuticals 
3:1296-1303. 
Inglis T.J., Sousa A.Q. (2009). The public health implications of 
melioidosis. Brazilian Journal of Infectious Diseases. 13:59-66. 
Janmaat A., Choy J.L., Currie B. (2004). Melioidosis in an alpaca 
(Lama pacos). Australian Veterinary Journal. 82:622-623. 
Jenney A.W., Lum G., Fisher D.A., Currie B.J. (2001). Antibiotic 
susceptibility of Burkholderia pseudomallei from tropical northern 
Australia and implications for therapy of melioidosis. International 
Journal of Antimicrobial Agents. 17:109-113. 
Katangwe T., Purcell J., Bar-Zeev N., Denis B., Montgomery J., 
Alaerts M., Heyderman R., Dance D.A., Kennedy N., Feasey N. (2013). 
Human melioidosis, Malawi, 2011. Emerging Infectious Diseases. 
19:981-984. 
Khosravi Y., Vellasamy K.M., Mariappan V., Ng S.-L., Vadivelu 
J. (2014). Antimicrobial Susceptibility and Genetic Characterisation of 
Burkholderia pseudomallei Isolated from Malaysian Patients. The 
Scientific World Journal. 2014. 
Kinoshita R.E. (2008). Melioidosis in Marine Mammals, in: M. E. 
Fowler and R. E. Miller (Eds.), Zoo and wild animal medicine: current 
therapy, Elsevier Health Sciences, Philadelphia, PA, USA. pp. 299-307. 
Ladds P., Thomas A., Pott B. (1981). Case Reports: Melioidosis 
with Acute Meningoencephalomyelitis in a Horse. Australian Veterinary 
Journal 57:36-38. 
Leelarasamee A., Bovornkitti S. (1989) Melioidosis: Review and 
update. Review of Infectious Diseases. 11:413-425. 
Limmathurotsakul D., Jamsen K., Arayawichanont A., Simpson 
J.A., White L.J., Lee S.J., Wuthiekanun V., Chantratita N., Cheng A., 
Day N. (2010). Defining the true sensitivity of culture for the diagnosis 
of melioidosis using Bayesian latent class models. PloS One. 5:e12485. 
Lipsitz R., Garges S., Aurigemma R., Baccam P., Blaney D.D., 
Cheng A.C., Currie B.J., Dance D., Gee J.E., Larsen J. (2012). 
Workshop on Treatment of and Postexposure Prophylaxis for 
Burkholderia pseudomallei and B. mallei Infection, 2010. Emerging 
Infectious Diseases. 18:e2. 
Livermore D.M. (1987). Mechanisms of resistance to 
cephalosporin antibiotics. Drugs. 34:64-88. 
McCombie R.L., Finkelstein R.A., Woods D.E. (2006). 
Multilocus sequence typing of historical Burkholderia pseudomallei 
isolates collected in Southeast Asia from 1964 to 1967 provides insight 
into the epidemiology of melioidosis. Journal of Clinical Microbiology. 
44:2951-2962. 
McCormick J.B., Sexton D.J., McMurray J.G., Carey E., Hayes 
P., Feldman R.A. (1975). Human-to-human transmission of 
Pseudomonas pseudomallei. Annals of Internal Medicine. 83:512-513. 
McRobb E., Kaestli M., Price E.P., Sarovich D.S., Mayo M., 
Warner J., Spratt B.G., Currie B.J. (2014). Distribution of Burkholderia 
pseudomallei in Northern Australia, a Land of Diversity. Applied and 
Environmental Microbiology. 80:3463-3468. 
Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods 
D.E. (1999). Efflux-mediated aminoglycoside and macrolide resistance 
in Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy. 
43:465-470. 
Mukhopadhyay C., Vandana K., Krishna S., Saravu K., Shastri B. 
(2009). Aquatic to pulmonary: Severe melioidosis following near-
drowning from Southern India. The Internet Journal of Pulmonary 
Medicine. 11:1-9. 
Najdenski H., Kussovski V., Vesselinova A. (2004). 
Experimental Burkholderia pseudomallei infection of pigs. Journal of 
Veterinary Medicine, Series B 51:225-230. 
O'Brien C., Krockenberger M., Martin P., Parkes H., Kidd M., 
Malik R. (2003). Disseminated melioidosis in two cats. Journal of Feline 
Medicine and Surgery. 5:83-89. 
Omar A. (1963). Pathology of Melioidosis in Pigs, Goats and a 
Horse. Journal of comparative pathology. 73:359. 
Ouadah A., Zahedi M., Perumal R. (2007). Animal melioidosis 
surveillance in Sabah. The Internet Journal of Veterinary Medicine. 2. 
Pearson T., Giffard P., Beckstrom-Sternberg S., Auerbach R., 
Hornstra H., Tuanyok A., Price E.P., Glass M.B., Leadem B., 
Beckstrom-Sternberg J.S. (2009). Phylogeographic reconstruction of a 
bacterial species with high levels of lateral gene transfer. BMC Biology. 
7:78. 
Pruekprasert P., Jitsurong S. (1991). Case report: septicemic 
melioidosis following near drowning. Southeast Asian Journal Tropical 
Medical Public Health. 22:276-8. 
Puthucheary S.D., Vadivelu J. (2002). Human melioidosis 
Singapore University Press, Yusof Ishak House, 31 Lower Kent Ridge 
Road, Singapore 119078. 
Sam I.-C., See K.H., Puthucheary S.D. (2009). Variations in 
ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal 
infection of Burkholderia pseudomallei. Journal of Clinical 
Microbiology. 47:1556-1558. 
Sanders K., Grismer L., Chan-Ard T. (2012). Acrochordus 
javanicus, The IUCN Red List of Threatened Species 2012: 
e.T176718A1443749. http://dx.doi.org/10.2305/IUCN.UK.2012-
1.RLTS.T176718A1443749.en. Downloaded on 20 June 2016. 
Schweizer H.P. (2012). Mechanisms of antibiotic resistance in 
Burkholderia pseudomallei: implications for treatment of melioidosis. 
Future Microbiology. 7:1389-1399. 
Simpson A.J., White N.J., Wuthiekanun V. (1999). 
Aminoglycoside and macrolide resistance in Burkholderia pseudomallei. 
Antimicrobial agents and Chemotherapy. 43:2332-2332. 
Sprague L., Neubauer H. (2004) Melioidosis in animals: a review 
on epizootiology, diagnosis and clinical presentation. Journal of 
Veterinary Medicine, Series B 51:305-320. 
Srikawkheaw N., Lawhavinit O. (2007). Detection of antibodies 
against melioidosis from animal sera in Thailand by indirect 
haemagglutination test. Kasetsart Journal of Nature Science. 41:81-5. 
Vesaratchavest M., Tumapa S., Day N.P., Wuthiekanun V., 
Chierakul W., Holden M.T., White N.J., Currie B.J., Spratt B.G., Feil 
E.J. (2006). Nonrandom distribution of Burkholderia pseudomallei 
clones in relation to geographical location and virulence. Journal of 
Clinical Microbiology. 44:2553-2557. 
Walsh A., Wuthiekanun V. (1996). The laboratory diagnosis of 
melioidosis. British Journal of Biomedical Science. 53:249-253. 
White N. (2003). Melioidosis. The Lancet 361:1715-1722. 
J. Vet. Malaysia (2016) 28 (1):20-26 
26 
 
Yap E., Thong T., Tan A., Yeo M., Tan H., Loh H., Teo T., 
Thong K., Singh M., Chan Y. (1995). Comparison of Pseudomonas 
pseudomallei from humans, animals, soil and water by restriction 
endonuclease analysis. Singapore Medical Journal. 36:60-62. 
Zehnder A.M., Hawkins M.G., Koski M.A., Lifland B., Byrne 
B.A., Swanson A.A., Rood M.P., Gee J.E., Elrod M.G., Beesley C.A., 
Blaney D.D., Ventura J., Hoffmaster A.R., Beeler E.S. (2014) 
Burkholderia pseudomallei Isolates in 2 Pet Iguanas, California, USA. 
Emerging Infectious Diseases. 20:304-306. 
 
 
 
